血液透析治疗直肠癌合并尿毒症的研究

Treatment of Rectal Cancer in Hemodialysis Patients with Uremia

目的研究直肠癌合并尿毒症血液透析患者的治疗。方法56例直肠癌患者,依据合并尿毒症血液透析治疗情况分为合并组(n=28)、未合并组(n=28)两组,均接受腹腔镜辅助右半结肠切除术治疗,统计分析两组患者的手术相关指标、术后并发症发生情况。结果合并组患者的住院时间显著长于未合并组(P<0.05),但两组患者的手术时间、术中出血量、淋巴结清扫数、术后引流量、肛门排气时间之间的差异均不显著(P>0.05)。合并组和未合并组患者的术后并发症发生率差异不显著(P>0.05)。结论直肠癌合并尿毒症血液透析治疗患者接受腹腔镜辅助右半结肠切除术治疗安全可行。

Objective This paper aims to study the treatment of rectal cancer patients with uremia treated by hemodialysis.Methods 56 patients with rectal cancer were retrospectively selected and divided into the combined group(n=28)and the non-combined group(n=28)according to the hemodialysis treatment of uremia.Both groups received laparoscopic assisted right hemicolectomy,and the operation related indicators and postoperative complications of the two groups were statistically analyzed.Results The hospitalization time of the combined group was significantly longer than that of the non-combined group(P<0.05),but there was no significant difference in the operation time,intraoperative blood loss,number of lymph node dissection,postoperative drainage volume and anal exhaust time between the two groups(P>0.05).There was no significant difference in the incidence of postoperative complications between the two groups(P>0.05).Conclusion Laparoscopic hemicolectomy combined with hemodialysis is safe for rectal cancer patients.